Anna Solini
Via Savi 10
Pisa, 56126, Italy
Pisa, 56126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
From Environmental Evidence to Biomarker Selection: A Structured Decision-Support Process for Human Biomonitoring Studies in Contaminated Sites.
Journal: Toxics
Published: May 15, 2026
Mortality and persistence in therapy in elderly subjects with type 2 diabetes receiving gliflozins or incretins.
Journal: Journal of endocrinological investigation
Published: May 06, 2026
Nephrin is produced in visceral adipose tissue in humans and associates with insulin resistance.
Journal: Diabetes research and clinical practice
Published: February 10, 2026
Quantifying the individual disease duration-adjusted burden of complications in persons with type 2 diabetes.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 03, 2026
Additional benefits of combining GLP-1 receptor agonist use with lifestyle modification.
Journal: The lancet. Diabetes & endocrinology
Published: January 20, 2026
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 Diabetes.
Journal: Diabetes/metabolism research and reviews
Published: October 24, 2025
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes.
Journal: Cardiovascular diabetology
Published: September 13, 2025
Severe obesity associates with maladaptive glomerular haemodynamics clustered with insulin resistance and endothelial dysfunction.
Journal: Clinical kidney journal
Published: September 05, 2025
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.
Journal: Diabetes, obesity & metabolism
Published: July 22, 2025
Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric study.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: July 10, 2025
Cardiovascular risk in type 1 versus type 2 diabetes.
Journal: The lancet. Diabetes & endocrinology
Published: June 18, 2025
Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: June 05, 2025
Last Updated: 09/26/2026